| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/07/2013 | US20130059807 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| 03/07/2013 | US20130059801 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | US20130059799 Aromatic-cationic peptides and uses of same |
| 03/07/2013 | US20130059781 Long-Acting Gastrin Derivatives |
| 03/07/2013 | US20130059780 Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| 03/07/2013 | US20130059778 Identification of a Genetic Risk Factor for Diabetes |
| 03/07/2013 | US20130059777 Modulation of glucose-6-phosphatase translocase expression |
| 03/07/2013 | US20130059770 Polypeptides |
| 03/07/2013 | US20130059768 Lipid compositions with high dha content |
| 03/07/2013 | US20130059005 Bupropion hydrobromide polymorphs |
| 03/07/2013 | US20130059002 Pharmaceutical compositions comprising a combination of metformin and sitagliptin |
| 03/07/2013 | US20130059000 Oral delivery for hemoglobin based oxygen carriers |
| 03/07/2013 | US20130058999 Pharmaceutical compositions for oral administration of insulin peptides |
| 03/07/2013 | US20130058995 Composition and method for weight reduction |
| 03/07/2013 | US20130058970 Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines |
| 03/07/2013 | US20130058944 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 03/07/2013 | US20130058942 Human beta-adrenergic receptor kinase polypeptide and methods |
| 03/07/2013 | US20130058941 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 03/07/2013 | US20130058919 Optimized Fc Variants and Methods for their Generation |
| 03/07/2013 | US20130058913 Lactase Formulations |
| 03/07/2013 | US20130058898 Lactic acid bacterium-containing preparation |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2878005A1 Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodites to microbiota of firmuctes phylum |
| 03/07/2013 | CA2857374A1 Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity |
| 03/07/2013 | CA2851602A1 Method for preventing and/or treating insulin resistance |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847017A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | CA2846845A1 Methods and compositions for promoting glucose homeostasis |
| 03/07/2013 | CA2845785A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845357A1 Method of treating or ameliorating type 1 diabetes using fgf21 |
| 03/07/2013 | CA2845169A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845159A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2845127A1 Pyrazole compound and pharmaceutical use thereof |
| 03/06/2013 | EP2565275A1 Method of treatment of vascular complications using modulators of TRX and TRXNIP |
| 03/06/2013 | EP2565205A1 Glucagon-like peptide-1 analogue and use thereof |
| 03/06/2013 | EP2565190A1 Tetrahydrobenzothiophene compound |
| 03/06/2013 | EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/06/2013 | EP2564866A2 Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | EP2564860A2 Yeast hydrolysate having obesity treatment effects and antioxidant activity |
| 03/06/2013 | EP2564843A1 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/06/2013 | EP2564842A1 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/06/2013 | EP2563930A2 Method for diagnosing risk of type 1 diabetes and for preventing onset of type 1 diabetes |
| 03/06/2013 | EP2563785A1 Compounds as agonists of s1p1 receptors |
| 03/06/2013 | EP2563780A1 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1]oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thiophen-3 -yl]methanones as inhibitors of 11 (beta) -hsd1 |
| 03/06/2013 | EP2563765A1 Bicyclic compound derivatives and their use as acc inhibitors. |
| 03/06/2013 | EP2563477A1 Methods and compositions for inducing satiety |
| 03/06/2013 | EP2563398A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans |
| 03/06/2013 | EP2563383A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| 03/06/2013 | EP2563382A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases |
| 03/06/2013 | EP2563381A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
| 03/06/2013 | EP2563380A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
| 03/06/2013 | EP2563370A1 Use of a composition containing phospholipids and glycyrrhizinic acid for removing subcutaneous fat accumulations by means of subcutaneous lipolysis |
| 03/06/2013 | EP2563122A1 Chemical compounds |
| 03/06/2013 | CN202761744U Traditional Chinese medicine patch |
| 03/06/2013 | CN102958932A Modulators of 5-HT receptors and methods of use thereof |
| 03/06/2013 | CN102958919A Novel tetrahydroquinoline derivatives |
| 03/06/2013 | CN102958908A New polymorphic form of calcimimetic compound |
| 03/06/2013 | CN102958907A New polymorphic form of calcimimetic compound |
| 03/06/2013 | CN102958532A Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | CN102958518A Combination of a phosphoinositide 3-kinase inhibitor and an antidiabetic compound for use in the treatment of proliferative diseases |
| 03/06/2013 | CN102952738A Glossy privet fruit blood glucose reducing wine and brewing method thereof |
| 03/06/2013 | CN102952737A Dogwood blood glucose reducing wine and brewing method thereof |
| 03/06/2013 | CN102952736A Herba leonuri sugar reducing wine and preparation method |
| 03/06/2013 | CN102952735A Radix polygonati officinalis blood glucose reducing wine and brewing method thereof |
| 03/06/2013 | CN102952734A Pearl barley blood glucose reducing wine and brewing method thereof |
| 03/06/2013 | CN102952733A Fructus alpiniae oxyphyllae blood glucose reducing wine and brewing method thereof |
| 03/06/2013 | CN102952732A Lotus leaf blood glucose reducing wine and brewing method thereof |
| 03/06/2013 | CN102952731A Fructus rosae laevigatae blood glucose reducing wine and brewing method |
| 03/06/2013 | CN102952706A Radish seed weight-losing wine and brewing method |
| 03/06/2013 | CN102952705A Radix astragali weight-losing wine and brewing method |
| 03/06/2013 | CN102952702A Bitter orange weight-losing wine and brewing method |
| 03/06/2013 | CN102952699A Artemisia capillaries weight-losing wine and brewing method |
| 03/06/2013 | CN102952661A Method for preparing green tea health-care wine |
| 03/06/2013 | CN102952192A Fusion protein containing Exendin-4 and application thereof |
| 03/06/2013 | CN102952186A Peptide complex, pharmaceutical composition thereof, and preparation and application thereof |
| 03/06/2013 | CN102952139A Trans-3a-fluoropyrrolidine[3,4-C]benzo cyclocompound and preparation method thereof |
| 03/06/2013 | CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof |
| 03/06/2013 | CN102952104A Furan compound |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102949730A Drug fusant of specific binding GLP-1 (Glucagon-like peptide-1) receptor |
| 03/06/2013 | CN102949709A External gel used for treating diabetic foot, and preparation method and application thereof |
| 03/06/2013 | CN102949618A Multifunctional diet tea |
| 03/06/2013 | CN102949610A Production process of highland barley Fermentum Rubrum with high tocol content |
| 03/06/2013 | CN102949600A Preparation method of folium llicis latifoliae hypotensive capsule |
| 03/06/2013 | CN102949598A Pill for alleviating diabetic symptoms and preparation method thereof |
| 03/06/2013 | CN102949597A Pure dendrobium officinale kimura et migo buccal tablets and preparation method thereof |
| 03/06/2013 | CN102949596A Radix trichosanthis blood glucose reducing wine and brewing method thereof |
| 03/06/2013 | CN102949588A Preparation method of fragrant solomonseal rhizome-poris cocos thirst-quenching tea |
| 03/06/2013 | CN102949587A Compound propolis preparation for auxiliary reduction of blood sugar, and its preparation method |
| 03/06/2013 | CN102949578A Traditional Chinese medicine for treating diabetic foot |
| 03/06/2013 | CN102949565A Catbrier blood-sugar reducing liquor and preparation method |
| 03/06/2013 | CN102949563A Pure traditional Chinese medicine health-care granule for treating diabetes mellitus and preparation method thereof |
| 03/06/2013 | CN102949560A Traditional Chinese medicinal prescription for treating hyperlipidemia |
| 03/06/2013 | CN102949555A Medicine for treating diabetic feet |
| 03/06/2013 | CN102949548A Pure traditional Chinese medicine health care product oral liquid for losing weight and preparation method thereof |
| 03/06/2013 | CN102949535A Chinese herbal preparation resistant to hyperlipidemia and atherosclerosis and preparation method of Chinese herbal preparation |
| 03/06/2013 | CN102949517A Chinese wolfberry root-bark pure powder buccal tablets and preparation method thereof |
| 03/06/2013 | CN102949492A Salvia weight-losing wine and brewing method |
| 03/06/2013 | CN102949482A Medicinal composition used for assisting in reducing blood fat and preparation method thereof |